gvtcx

Evaluation of a possible dry heat sterilisation mechanism for HI-6

Defence Science and Technology Laboratory Published 19 Aug 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£86,387
Statuscomplete
Category (CPV) 24950000 +3 more
Deadline13 Jul 2022
Contract start14 Jul 2022
Contract end7 Dec 2022
Procedureselective
SME suitableNo
OCIDocds-b5fd17-847b8a27-144d-4b77-ab9f-0d14122ccdcd

Award

SupplierValueDateStatus
LUCIDEON LIMITED £72,647 11 Jul 2022 active

description

This is a notice of intended award of a task under RCloud, it is not open for response

A contractor is required to provide a proof of principle study evaluating possible dry heat sterilisation exposure times/temperatures which cause minimal change in the Active Pharmaceutical Ingredient supplied.

Dstl is developing a sterile dry powder pharmaceutical product for intravenous administration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
19 Aug 2022 Award update (awardUpdate) · 86da663b-efdc-48f9-9fb4-cc2d282c5915-565370

more from Defence Science and Technology Laboratory

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.